Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $48.42 | 2 | 52.5% |
| Education | $43.89 | 3 | 47.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $43.89 | 3 | $0 (2018) |
| Boston Scientific Corporation | $25.34 | 1 | $0 (2022) |
| Axonics, Inc. | $23.08 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $23.08 | 1 | Axonics, Inc. ($23.08) |
| 2022 | $25.34 | 1 | Boston Scientific Corporation ($25.34) |
| 2018 | $43.89 | 3 | PFIZER INC. ($43.89) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/28/2023 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Urology | ||||||
| 11/09/2022 | Boston Scientific Corporation | rezum Generator (Device) | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: rezum_URO | ||||||
| 11/20/2018 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 11/05/2018 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 09/10/2018 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,455 | 1,828 | $303,332 | $81,372 |
| 2022 | 12 | 1,584 | 1,839 | $269,267 | $70,730 |
| 2021 | 10 | 1,447 | 1,696 | $282,183 | $80,247 |
| 2020 | 10 | 1,342 | 1,530 | $252,842 | $63,281 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 90 | 128 | $68,352 | $24,198 | 35.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 306 | 366 | $79,422 | $22,773 | 28.7% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2021 | 16 | 23 | $43,056 | $10,943 | 25.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 197 | 217 | $28,210 | $9,619 | 34.1% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 63 | 63 | $13,986 | $3,595 | 25.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 37 | 37 | $11,840 | $2,784 | 23.5% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2021 | 258 | 290 | $14,790 | $2,174 | 14.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 25 | 25 | $8,032 | $1,731 | 21.5% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 14 | 15 | $3,855 | $1,234 | 32.0% |
| 81003 | Automated urinalysis test | Office | 2021 | 441 | 532 | $10,640 | $1,197 | 11.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 385 | 436 | $90,468 | $22,375 | 24.7% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2020 | 94 | 122 | $65,148 | $20,227 | 31.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 100 | 122 | $37,108 | $8,851 | 23.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 29 | 29 | $12,267 | $3,646 | 29.7% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 45 | 45 | $13,518 | $3,178 | 23.5% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2020 | 222 | 240 | $12,240 | $1,817 | 14.8% |
| 55700 | Biopsy of prostate gland | Facility | 2020 | 12 | 12 | $6,816 | $1,354 | 19.9% |
| 81003 | Automated urinalysis test | Office | 2020 | 429 | 498 | $9,960 | $1,111 | 11.2% |
| 76872 | Ultrasound of rectum | Facility | 2020 | 13 | 13 | $3,250 | $370.66 | 11.4% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Facility | 2020 | 13 | 13 | $2,067 | $350.49 | 17.0% |
About Dr. Robert Cherry, MD
Dr. Robert Cherry, MD is a Urology healthcare provider based in Charlton, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1821073982.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Cherry, MD has received a total of $92.31 in payments from pharmaceutical and medical device companies, with $23.08 received in 2023. These payments were reported across 5 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($48.42).
As a Medicare-enrolled provider, Cherry has provided services to 5,828 Medicare beneficiaries, totaling 6,893 services with total Medicare billing of $295,630. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Charlton, MA
- Active Since 12/13/2005
- Last Updated 03/05/2015
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1821073982
Products in Payments
- XTANDI (Drug) $43.89
- rezum Generator (Device) $25.34
- Axonics (Device) $23.08
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.